When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
PFE - Vaccinex up 10% on updated pepinemab data in lung cancer
Pfizer Inc.
Thinly traded nano cap Vaccinex (VCNX+9.8%) is up more than an 8x surge in volume, albeit on turnover of only 289K shares, on the heels of updated data from a Phase 1b/2 clinical trial, CLASSICAL-Lung, evaluating pepinemab, combined with Pfizer (PFE+1.5%) and Merck KGaA's (OTCPK:MKGAY) Bavencio (avelumab), in non-small cell lung cancer (NSCLC) patients. The results were presented at the American Association for Cancer Research (AACR) Virtual Annual Meeting.
More news on: Vaccinex, Inc., Pfizer Inc., Merck KGaA ADR, Healthcare stocks news, Stocks on the move,